Sandra Moreno

Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo

Horacio Almanza‐Reyes, Sandra Moreno, Ismael Plascencia López et al. · PLoS ONE · 2021 · 94 citations · Full text

Life Sciences, Infectious Disease Control, Infectious Diseases +15

Control of<i>Mycobacterium tuberculosis</i>growth by activated natural killer cells

Carlos Guerra, K Johal, Devin Morris et al. · Clinical & Experimental Immunology · 2011 · 77 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A protective bivalent vaccine against Rift Valley fever and bluetongue

Eva Calvo-Pinilla, Alejandro Marín-López, Sandra Moreno et al. · npj Vaccines · 2020 · 36 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Vulnerability of SARS-CoV-2 and PR8 H1N1 virus to cold atmospheric plasma activated media

O. D. Cortázar, A. Megía-Macías, Sandra Moreno et al. · Scientific Reports · 2022 · 28 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus

Sergio Utrilla-Trigo, Luís Jiménez-Cabello, Ruymán Alonso-Ravelo et al. · Vaccines · 2020 · 27 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17